1. Home
  2. EVEX vs DBVT Comparison

EVEX vs DBVT Comparison

Compare EVEX & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$2.48

Market Cap

888.2M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$14.14

Market Cap

948.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
DBVT
Founded
2020
2002
Country
United States
France
Employees
N/A
90
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
888.2M
948.8M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
EVEX
DBVT
Price
$2.48
$14.14
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$6.88
$32.04
AVG Volume (30 Days)
931.0K
341.3K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
$11,676.47
$2,360.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.77
52 Week Low
$2.10
$8.80
52 Week High
$5.16
$26.19

Technical Indicators

Market Signals
Indicator
EVEX
DBVT
Relative Strength Index (RSI) 46.51 47.20
Support Level $2.26 $12.75
Resistance Level $2.56 $14.68
Average True Range (ATR) 0.16 0.69
MACD -0.02 0.14
Stochastic Oscillator 4.26 57.45

Price Performance

Historical Comparison
EVEX
DBVT

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: